Literature DB >> 18698303

Intravitreal silicone oil droplets after intravitreal drug injections.

Sophie J Bakri1, Noha S Ekdawi.   

Abstract

PURPOSE: To present the finding of tiny silicone oil droplets in 15 eyes of 15 patients after intravitreal injections of an anti-vascular endothelial growth factor agent or triamcinolone acetonide and to discuss the likely source of silicone oil.
METHODS: In an observational case series, charts of patients who had undergone intravitreal injections by one surgeon were reviewed retrospectively. The finding of intravitreal silicone oil droplets was noted. The following information was also documented: number and type of injections before the appearance of silicone oil droplets, symptoms and evidence of ocular inflammation, visual acuity before and after silicone oil droplets, length of follow-up, and visual acuity at the last examination.
RESULTS: Fifteen eyes of 15 patients were found to have silicone oil droplets documented after a various number of injections (range, 1-16). Patients were asymptomatic, and there were no adverse side effects associated with the presence of silicone oil droplets at examination.
CONCLUSIONS: Silicone oil droplets may occur in the vitreous cavity after intravitreal drug injections. There were no adverse effects found associated with silicone oil in the vitreous after injections of anti-vascular endothelial growth factor agents or triamcinolone acetonide. The likely source of silicone oil is the needles and syringes used for the injections.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18698303     DOI: 10.1097/IAE.0b013e31816c6868

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  23 in total

1.  Incidence of Presumed Silicone Oil Droplets in the Vitreous Cavity After Intravitreal Bevacizumab Injection With Insulin Syringes.

Authors:  Rahul N Khurana; Louis K Chang; Travis C Porco
Journal:  JAMA Ophthalmol       Date:  2017-07-01       Impact factor: 7.389

2.  A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5.

Authors:  Michael S Ip; Ingrid U Scott; Paul C VanVeldhuisen; Neal L Oden; Barbara A Blodi; Marian Fisher; Lawrence J Singerman; Michael Tolentino; Clement K Chan; Victor H Gonzalez
Journal:  Arch Ophthalmol       Date:  2009-09

3.  Intraocular pressure changes related to intravitreal injections of ranibizumab: analysis of pseudophakia and glaucoma subgroup.

Authors:  Sibel Demirel; Ozge Yanik; Figen Batioglu; Emin Ozmert
Journal:  Int Ophthalmol       Date:  2014-07-31       Impact factor: 2.031

4.  A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6.

Authors:  Ingrid U Scott; Michael S Ip; Paul C VanVeldhuisen; Neal L Oden; Barbara A Blodi; Marian Fisher; Clement K Chan; Victor H Gonzalez; Lawrence J Singerman; Michael Tolentino
Journal:  Arch Ophthalmol       Date:  2009-09

5.  SCORE Study Report 7: incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design.

Authors:  Ingrid U Scott; Neal L Oden; Paul C VanVeldhuisen; Michael S Ip; Barbara A Blodi; Andrew N Antoszyk
Journal:  Am J Ophthalmol       Date:  2009-08-11       Impact factor: 5.258

Review 6.  Ocular hypertension following intravitreal anti-vascular endothelial growth factor agents.

Authors:  Ravi S J Singh; Judy E Kim
Journal:  Drugs Aging       Date:  2012-12       Impact factor: 3.923

7.  Intraocular Pressure Changes after Intravitreal Bevacizumab or Ranibizumab Injection: A Retrospective Study.

Authors:  Tarannum Mansoori; Satish Gooty Agraharam; Sunny Manwani; Nagalla Balakrishna
Journal:  J Curr Ophthalmol       Date:  2021-03-26

8.  Sustained intraocular pressure elevation after intravitreal injection of bevacizumab and ranibizumab associated with trabeculitis.

Authors:  Matthew Sniegowski; Naresh Mandava; Malik Y Kahook
Journal:  Open Ophthalmol J       Date:  2010-06-22

9.  Presumed pyogenic granuloma associated with intravitreal anti-vascular endothelial growth factor therapy.

Authors:  Jesse J Jung; Kara E Della Torre; Millie R Fell; Christopher C Teng; K Bailey Freund
Journal:  Open Ophthalmol J       Date:  2011-12-19

10.  Evaluation of intraocular pressure elevation after multiple injections of intravitreal ranibizumab.

Authors:  Alice L Yu; Florian Seidensticker; Markus Schaumberger; Ulrich Welge-Lussen; Armin Wolf
Journal:  Clin Ophthalmol       Date:  2014-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.